Cargando…

Circulating Serum Trefoil Factor 3 (TFF3) Is Dramatically Increased in Chronic Kidney Disease

OBJECTIVES: Trefoil factor 3 (TFF3) is a small peptide that plays an important role in mucosal protection, cell proliferation, and cell migration. The aberrant expression of TFF3 is correlated with gastrointestinal inflammation, solid tumors, and other clinical diseases. The objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Ting-yi, Luo, Hui-ming, Qin, Hai-chun, Wang, Fang, Wang, Qing, Xiang, Yang, Zhang, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840008/
https://www.ncbi.nlm.nih.gov/pubmed/24282531
http://dx.doi.org/10.1371/journal.pone.0080271
_version_ 1782478467387883520
author Du, Ting-yi
Luo, Hui-ming
Qin, Hai-chun
Wang, Fang
Wang, Qing
Xiang, Yang
Zhang, Yun
author_facet Du, Ting-yi
Luo, Hui-ming
Qin, Hai-chun
Wang, Fang
Wang, Qing
Xiang, Yang
Zhang, Yun
author_sort Du, Ting-yi
collection PubMed
description OBJECTIVES: Trefoil factor 3 (TFF3) is a small peptide that plays an important role in mucosal protection, cell proliferation, and cell migration. The aberrant expression of TFF3 is correlated with gastrointestinal inflammation, solid tumors, and other clinical diseases. The objective of this study was to identify the distribution characteristics of serum TFF3 in common clinical diseases. MATERIALS AND METHODS: A large prospective randomized study of 1,072 Chinese patients was performed using an enzyme-linked immunosorbent assay (ELISA) to examine the serum TFF3 concentrations in patients with different diseases. A matched case-control study was conducted on patients with chronic kidney disease (CKD) stages 1–5. Immunohistochemistry (IHC) was performed using renal tissues to determine the relationship between the severity of CKD and the serum and urine concentrations of TFF3 peptides. RESULTS: The mean serum concentrations of TFF3 in patients with CKD, metastatic and secondary carcinoma (MC) and acute gastroenteritis (AG) (200.9 ng/ml, 95.7 ng/ml and 71.7 ng/ml, respectively) were significantly higher than those in patients with other common clinical diseases. A positive correlation tendency was observed between the serum TFF3 concentrations and the severity of CKD. The mean serum TFF3 values for CKD stages 1–5 were 23.6 ng/ml, 29.9 ng/ml, 54.9 ng/ml, 85.0 ng/ml and 176.6 ng/ml, respectively. The same trend was observed in the urine TFF3 concentrations and the CKD stages. The creatinine(Cr)-corrected concentrations of TFF3 in urine were 367.1 ng/mg·Cr, 910.6 ng/mg·Cr, 1,149.0 ng/mg·Cr, 1,610.0 ng/mg·Cr and 3,475.0 ng/mg·Cr for CKD stages 1–5, respectively. IHC revealed that TFF3 expression was concentrated in tubular epithelial cells. CONCLUSIONS: The influence of kidney injuries must be fully considered when performing clinical TFF3 research. Further studies on TFF3 in CKD will contribute to our understanding of its pathological roles and mechanisms in other diseases.
format Online
Article
Text
id pubmed-3840008
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38400082013-11-26 Circulating Serum Trefoil Factor 3 (TFF3) Is Dramatically Increased in Chronic Kidney Disease Du, Ting-yi Luo, Hui-ming Qin, Hai-chun Wang, Fang Wang, Qing Xiang, Yang Zhang, Yun PLoS One Research Article OBJECTIVES: Trefoil factor 3 (TFF3) is a small peptide that plays an important role in mucosal protection, cell proliferation, and cell migration. The aberrant expression of TFF3 is correlated with gastrointestinal inflammation, solid tumors, and other clinical diseases. The objective of this study was to identify the distribution characteristics of serum TFF3 in common clinical diseases. MATERIALS AND METHODS: A large prospective randomized study of 1,072 Chinese patients was performed using an enzyme-linked immunosorbent assay (ELISA) to examine the serum TFF3 concentrations in patients with different diseases. A matched case-control study was conducted on patients with chronic kidney disease (CKD) stages 1–5. Immunohistochemistry (IHC) was performed using renal tissues to determine the relationship between the severity of CKD and the serum and urine concentrations of TFF3 peptides. RESULTS: The mean serum concentrations of TFF3 in patients with CKD, metastatic and secondary carcinoma (MC) and acute gastroenteritis (AG) (200.9 ng/ml, 95.7 ng/ml and 71.7 ng/ml, respectively) were significantly higher than those in patients with other common clinical diseases. A positive correlation tendency was observed between the serum TFF3 concentrations and the severity of CKD. The mean serum TFF3 values for CKD stages 1–5 were 23.6 ng/ml, 29.9 ng/ml, 54.9 ng/ml, 85.0 ng/ml and 176.6 ng/ml, respectively. The same trend was observed in the urine TFF3 concentrations and the CKD stages. The creatinine(Cr)-corrected concentrations of TFF3 in urine were 367.1 ng/mg·Cr, 910.6 ng/mg·Cr, 1,149.0 ng/mg·Cr, 1,610.0 ng/mg·Cr and 3,475.0 ng/mg·Cr for CKD stages 1–5, respectively. IHC revealed that TFF3 expression was concentrated in tubular epithelial cells. CONCLUSIONS: The influence of kidney injuries must be fully considered when performing clinical TFF3 research. Further studies on TFF3 in CKD will contribute to our understanding of its pathological roles and mechanisms in other diseases. Public Library of Science 2013-11-25 /pmc/articles/PMC3840008/ /pubmed/24282531 http://dx.doi.org/10.1371/journal.pone.0080271 Text en © 2013 Du et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Du, Ting-yi
Luo, Hui-ming
Qin, Hai-chun
Wang, Fang
Wang, Qing
Xiang, Yang
Zhang, Yun
Circulating Serum Trefoil Factor 3 (TFF3) Is Dramatically Increased in Chronic Kidney Disease
title Circulating Serum Trefoil Factor 3 (TFF3) Is Dramatically Increased in Chronic Kidney Disease
title_full Circulating Serum Trefoil Factor 3 (TFF3) Is Dramatically Increased in Chronic Kidney Disease
title_fullStr Circulating Serum Trefoil Factor 3 (TFF3) Is Dramatically Increased in Chronic Kidney Disease
title_full_unstemmed Circulating Serum Trefoil Factor 3 (TFF3) Is Dramatically Increased in Chronic Kidney Disease
title_short Circulating Serum Trefoil Factor 3 (TFF3) Is Dramatically Increased in Chronic Kidney Disease
title_sort circulating serum trefoil factor 3 (tff3) is dramatically increased in chronic kidney disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840008/
https://www.ncbi.nlm.nih.gov/pubmed/24282531
http://dx.doi.org/10.1371/journal.pone.0080271
work_keys_str_mv AT dutingyi circulatingserumtrefoilfactor3tff3isdramaticallyincreasedinchronickidneydisease
AT luohuiming circulatingserumtrefoilfactor3tff3isdramaticallyincreasedinchronickidneydisease
AT qinhaichun circulatingserumtrefoilfactor3tff3isdramaticallyincreasedinchronickidneydisease
AT wangfang circulatingserumtrefoilfactor3tff3isdramaticallyincreasedinchronickidneydisease
AT wangqing circulatingserumtrefoilfactor3tff3isdramaticallyincreasedinchronickidneydisease
AT xiangyang circulatingserumtrefoilfactor3tff3isdramaticallyincreasedinchronickidneydisease
AT zhangyun circulatingserumtrefoilfactor3tff3isdramaticallyincreasedinchronickidneydisease